Oregon Urology Institute
2400 Hartman Lane
Springfield, OR 97477

Prostate Cancer – Medivation
Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy
Study Intervention Model: Parallel
Assignment Masking: Double Blind
(Subject, Investigator)
Primary Purpose: Treatment
Official Title: A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation TherapyFor more information on this study visitclinicaltrials.gov
Prostate Cancer – PRIME
Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TFor more information on this study visit
clinicaltrials.gov

Active Trials

 

Prostate Cancer – Dendreon PROCEED
Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Registry of Sipuleucel-T
Therapy in Men
With Advanced Prostate Cancer
For More information on this study visitclinicaltrials.gov

Source: Oregon Urology Institue: Clinical Trials

Leave a Comment